Pharmacogenomics, the study of how genetic variability influences individual responses to drugs, has opened new frontiers in the era of personalized medicine. The integration of 3D printing into pharmaceutical sciences further advances this paradigm by enabling customized drug dosing, combinations, and release profiles tailored to an individual’s genetic makeup. This study examines the role of 3D-printed medicines in pharmacogenomics, the technological advancements supporting personalized prescriptions, regulatory challenges, and the potential for integrating genomic data with additive manufacturing technologies to enable individualized drug therapy.
Joshi et al. (Thu,) studied this question.